NEW YORK (GenomeWeb News) – The Biomedical Diagnostics Institute in Dublin, Ireland, said today that it has purchased one of Biacore’s label-free protein interaction systems for its diagnostics research programs.
BDI said it will use Biacore’s A100 system to help develop diagnostics for cardiac conditions, cancer, blood coagulation and monitoring, and for mastitis in cattle.
The institute used funds from Science Foundation Ireland to buy the system, and said it is the first academic research institute in Europe to install one.
The institute is a partnership between academic, industry, and clinical collaborators that was founded three years ago, and is aimed at developing point-of-care, self-test, and home-use diagnostics.
BDI said the system’s ability to generate high quality and high content data, its parallel analysis, and its ability to analyze around 2,000 interactions in 24 hours were “key factors” in its decision to buy the Biacore system.
Financial terms of the agreement were not released.